Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03219333 |
|---|---|
| Brief Title: | A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (EV-201) |
| First Submitted : | July 13, 2017 |
| First Submitted that Met QC Criteria : | July 13, 2017 |
| First Posted : | July 17, 2017 |
| Results First Submitted : | October 26, 2021 |
| Results First Posted with QC Comments : | November 26, 2021 |
| Results First Submitted that Met QC Criteria : | December 16, 2021 |
| Results First Posted : | December 17, 2021 |
| Last Update Submitted that Met QC Criteria : | June 13, 2022 |
| Last Update Posted : | June 15, 2022 |